As of Oct 17
| +0.56 / +3.66%|
The 10 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 26.50, with a high estimate of 40.00 and a low estimate of 16.00. The median estimate represents a +67.09% increase from the last price of 15.86.
The current consensus among 10 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.